Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares following the Food and Drug Administration’s approval for Gomekli ...

Wedbush analyst Jay McCanless reiterated a Buy rating on Taylor Morrison (TMHC – Research Report) today and set a price target of $85.00. The ...

Shares of Oklo have soared 137% over the past month, gaining traction as a strong bet on nuclear energy’s role in powering AI ...

The NatWest share price is surging this year, helped by the growing profits and rotation towards European banks. It has ...

Wedbush analyst Daniel Ives remains highly bullish on Tesla (TSLA) stock despite the concerns surrounding CEO Elon Musk’s ...

Tesla (NASDAQ: TSLA) remains on track for long-term growth despite recent stock struggles, according to Wedbush. The firm reaffirmed its bullish outlook, citing Teslas advancements in autonomous ...

Tesla stock tumbled Tuesday as reports emerged late Monday that an investor group, headed by Tesla Chief Executive Elon Musk, launched an unsolicited takeover bid worth $97.4 billion for Sam Altman's ...

In terms of liquidity and interest, the mean open interest for Carvana options trades today is 532.95 with a total volume of ...

Super Micro Computer Inc. rose in premarket trading after giving an aggressive long-term revenue outlook and saying it ...

Investment analysts at Wedbush decreased their Q3 2025 earnings per share estimates for shares of Silicon Motion Technology in a report released on Thursday, February 6th. Wedbush analyst M. Bryson ...

Wedbush Securities adjusted its price target for Palo Alto Networks (NASDAQ:PANW) shares, reducing it from the previous $400.00 to $225.00, while retaining an Outperform rating for the cybersecurity ...

Here's why this Sam Altman-backed nuclear energy company almost soared more than 150% in 2025 and why it'll likely continue ...